SEGMENT REPORTING (Tables)

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

SCHEDULE OF INFORMATION ABOUT REPORTED SEGMENT PROFIT OR LOSS AND ASSETS

	Breast					COVID-19
	Cancer Test			Alzheimer		Testing			Total
	Unaudited
Nine months ended September 30, 2021
Revenues		-			-		7,773			7,773
Operating loss		(4,685	)		-		(996	)		(5,681	)
Unallocated amounts:
Financing expenses, net										(17,368	)
Share in losses of affiliated companies accounted for under equity method, net										(1,499	)
Net loss										(24,547	)
Total Assets		10,257			-		6,904			17,161
Other significant items:
Total expenditures for assets of reportable segment		2			-		933			935
Total depreciation for reportable segment		(22	)		-		(504	)		(526	)

SUMMARY OF REVENUES BY GEOGRAPHIC REGION

	Nine months period ended September 30,		Three months period ended September 30,		Nine months period ended September 30,		Three months period ended September 30,
	2021		2021		2020		2020
	Unaudited				Unaudited
Israel	$	-	$	-	$	-	$	-
United States		7,773		1,010		1,316		1,284
		7,773		1,010		1,316		1,284

SUMMARY OF PROPERTY AND EQUIPMENT, NET, BY GEOGRAPHIC AREA

	As of		As of
	September 30, 2021		December 31, 2020
	Unaudited
Israel	$	41	$	61
United States		2,550		1,938
	$	2,591	$	1,999